Lara Sullivan

Insider Reports History

Entity
Individual
Location
C/O Rexahn Pharmaceuticals, Inc., 15245 Shady Grove Road, Suite 455, Rockville, MD
Signature
/s/ Pamela Connealy, Attorney-in-Fact for Lara Sullivan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lara Sullivan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Pyxis Oncology, Inc. President ,CEO & CMO, Director Stock Option (Right to Buy) 918K $900K $0.98 Mar 31, 2025 Direct

Insider Reports Filed by Lara Sullivan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PYXS Pyxis Oncology, Inc. Mar 31, 2025 1 $900K 4 Apr 2, 2025 President ,CEO & CMO, Director
PYXS Pyxis Oncology, Inc. Dec 23, 2024 1 $0 4 Dec 23, 2024 Chief Executive Officer, Director
PYXS Pyxis Oncology, Inc. Mar 26, 2024 1 $4.1M 4 Mar 28, 2024 Chief Executive Officer, Director
PYXS Pyxis Oncology, Inc. Sep 14, 2023 2 -$18.2K 4 Sep 18, 2023 President and CEO, Director
PYXS Pyxis Oncology, Inc. Sep 11, 2023 4 -$457K 4 Sep 13, 2023 President and CEO, Director
PYXS Pyxis Oncology, Inc. Sep 7, 2023 1 $0 4 Sep 8, 2023 President and CEO, Director
PYXS Pyxis Oncology, Inc. Mar 24, 2023 5 $0 4 Mar 28, 2023 President and CEO, Director
PYXS Pyxis Oncology, Inc. Jan 3, 2023 1 $0 4 Jan 3, 2023 Chief Executive Officer, Director
PYXS Pyxis Oncology, Inc. Apr 14, 2022 1 $0 4 Apr 15, 2022 Chief Executive Officer, Director
PYXS Pyxis Oncology, Inc. Mar 31, 2022 1 $0 4 Apr 4, 2022 Chief Executive Officer, Director
PYXS Pyxis Oncology, Inc. Oct 7, 2021 1 $0 4 Oct 12, 2021 Chief Executive Officer, Director
PYXS Pyxis Oncology, Inc. Oct 7, 2021 0 $0 3 Oct 7, 2021 Chief Executive Officer, Director